ICD-10-CM › Q00-QA1 › QA0-QA1 › QA1.79 Other inherited neoplasm... › QA1.791
QA1.791
Familial cancer syndrome with pathogenic BRCA2 mutation
ValidICD-10-CM diagnosis code.
Valid for claims with a date of service in the current code year.
What has happened to this code
Every change the publisher made, from 2027 to now.
- FY2027 Added to the code set Familial cancer syndrome with pathogenic BRCA2 mutation
Official coding rules
Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.
Inherited from QA1 Genetic disorders associated with neoplasms, not elsewhere classified
Excludes2 - not included here
- multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Code also
- , if applicable, any associated conditions, such as:
- genetic susceptibility to malignant neoplasm by site (Z15.0-)
- malignant neoplasms (C00.0-C96.9)
- personal history of malignant neoplasm (Z85.-)
How CDC's index refers to this code
Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.
- Syndrome > BRCA2-cancer predisposition
- Syndrome > familial cancer > with > pathogenic BRCA2 mutation
- Syndrome > hereditary breast and ovarian cancer > with > pathogenic BRCA2 mutation
Codes in the same group
| Code | Description | Status |
|---|---|---|
| QA1.790 | Familial cancer syndrome with pathogenic BRCA1 mutation | Valid |
| QA1.792 | Li Fraumeni syndrome | Valid |
| QA1.798 | Other inherited neoplasm predisposition syndrome of multiple systems | Valid |